To search systematically for published, randomised controlled trials (RCTs) comparing propofol with methohexital for anaesthesia during electroconvulsive therapy (ECT). In addition, to critically appraise the data, to combine the data from independent trials, and to quantify any difference in efficacy and harm between these two hypnotics.
methodological validity, and any disagreements were resolved by consensus.
Data extraction
The data were extracted from the included studies by one author, with the other two authors assessing the adequacy of the data extraction process. Data were extracted on the patients' characteristics, the propofol and methohexital regimens, any concomitant drugs, and the end points of interest.
Methods of synthesis
How were the studies combined? Narrative and quantitative syntheses were undertaken. The weighted mean differences were calculated for continuous data (duration of seizures and duration of anaesthesia), along with 95% confidence intervals (CIs). The dose effects (association between the dose and the duration of seizure or anaesthesia) for both hypnotics were tested using a varianceweighted regression analysis of the natural logarithm of time for each study (see Other Publications of Related Interest no.2). The data synthesis was performed using a fixed-effect model (see Other Publications of Related Interest no.3) when the data were homogeneous (P greater than 0.1), and a random-effects model (see Other Publications of Related Interest no.4) when the data were not.
How were differences between studies investigated?
The authors do not state a method for assessing any differences between the studies.
Results of the review
Fifteen RCTs with a total of 706 participants, which compared propofol (349 participants) with methohexital (357 participants), were included.
The mean duration of seizures with propofol was significantly shorter than that with methohexital: the weighted mean difference (fixed-effect model) was 8.4 seconds (95% CI: 6.6, 10.0) for motor seizure, and 14.3 seconds (95% CI: 10.8, 17.8) for EEG seizure activity. For both hypnotics, the variance-weighted regression analysis of the natural logarithm of duration of seizure against dose did not indicate a clear correlation (r2) for either motor seizure (propofol, r2=0.25, P=0.08; methohexital, r2=0.11, P=0.27) or EEG seizure activity (propofol, r2=0.00001, P=0.99; methohexital, r2=0.21, P=0.25).
There was no significant difference in the duration of anaesthesia between propofol and methohexital: the weighted mean difference was 0.25 minutes (95% CI: 0.35, 0.85). For both hypnotics, the variance-weighted regression analysis of the natural logarithm of duration of anaesthesia against dose did not indicate any correlation (propofol, r2=0.00004, P=0.99; methohexital, r2=0.03, P=0.63). Three trials reported on improvement of the underlying disease at the end of an ECT series. One of these reported that a significantly greater number of participants showed improvement with propofol (86%), compared with those receiving methohexital (59%). Fourteen trials reported qualitatively on respiratory adverse events, e.g. hypoventilation; this was shown to occur with both hypnotics. Five trials reported adverse cardiovascular events. Qualitatively, there was on average a smaller increase in blood-pressure with propofol than with methohexital. One report described pain on injection with propofol.
Authors' conclusions
Propofol and methohexital are appropriate anaesthetics for patients undergoing ECT. There was little evidence of an association between dose and seizure duration with either hypnotic. Although propofol was associated with an improved outcome in two small reports, it is unknown whether that relation was causal. The duration of motor and EEG seizure activity is likely to be a surrogate end point for the efficacy of ECT; these end points should not be used in future assessments.
